Showing 1 - 20 of 53 results
The Australian Critical Minerals Research and Development Hub (the Hub) unites the expertise of top Federal science agencies: ANSTO, Geoscience Australia, and CSIRO with the aim of addressing technical challenges and drive collaborative research across the critical minerals value chain.
Our research group carries out fundamental research uniquely applied to industrial problems in the areas of uranium, rare earth and lithium processing.
Rare earth elements will be a key area of focus for the Australian Nuclear Science and Technology Organisation’s Minerals unit as it welcomes a $13.9 million funding allocation under the Australian Critical Minerals Research and Development Hub
ANSTO is seeking nominations for the ANSTO Australian Synchrotron Stephen Wilkins Thesis Medal.
ANSTO is seeking nominations for the ANSTO Australian Synchrotron Stephen Wilkins Thesis Medal.
ANSTO is seeking nominations for the ANSTO Australian Synchrotron Stephen Wilkins Thesis Medal.
Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia
ANSTO's Minerals team provides consultancy, process development and research services to the mining and minerals processing industries.
ANSTO is a highly regulated organisation. Our governance system and processes provide critical guidance to effectively manage ANSTO’s activities. This section outlines the processes and systems that are in place to provide assurance to Government, our stakeholders and the community that we are working within our regulated and mandated requirements.
ANSTO's Graduate Program develops the next generation of Australian business and science leaders, by providing the best and brightest postgraduate students with a two-year rotation cycle, tailored to match your talents, goals and interests.
For over 45 years, ANSTO has provided consultancy and process development services to the mining and minerals processing industries in Australia and globally.
The National Deuteration Facility offers access to deuterated molecules prepared by both in vivo biodeuteration and chemical deuteration techniques.
Our experienced team of engineers, metallurgists, chemists and scientists have a proven track record of working with our clients in Australia and around the world to design and evaluate novel flowsheets and improve established processes.
Cyclotek and ANSTO have announced the launch of a Joint Venture (JV), to establish Australia’s first GMP (Good Manufacturing Practice) theranostics facility starting in Melbourne, Australia.
Guidance for obtaining and maintaining human or animal ethics approval at the Australian Synchrotron.